Metacrine Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Metacrine Inc
CIK #0001634379
EDGAR Form CIK 2011 - 2026
10-K [0001634379]
10-Q [0001634379]
3 [0001634379]
4 [0001634379]
8-K [0001634379]
D [0001634379]
SC 13D [0001634379]
SC 13G [0001634379]
Form 13D/13G Filer Form 13D/13G Subject Filed
Tang Capital Partners LP Metacrine Inc [2022-12-19]
BML Investment Partners LP Metacrine Inc [2022-12-08]
BML Investment Partners LP Metacrine Inc [2022-02-18]
Alexandria Real Estate Equities Inc Metacrine Inc [2021-02-16]
venBio Global Strategic Fund LP Metacrine Inc [2021-02-16]
Polaris Partners VII LP Metacrine Inc [2021-02-12]
Arch Venture Fund VIII LP Metacrine Inc [2021-02-02]
Franklin Resources Inc Metacrine Inc [2021-02-02]
Flynn James E Metacrine Inc [2020-09-29]
New Enterprise Associates 16 LP Metacrine Inc [2020-09-28]
Form 3/4/5 Subject 2011 - 2026
Metacrine Inc
Klassen Preston
York Michael
Leonard Braden Michael
Guggenhime Andrew
Heyman Richard A
Evans Ronald M
Nashat Amir
Jonker Jeffrey David
McHutchison John G
Owens Julia C
Chang Carmen
Walker Paul Edward
Sonsini Peter W
Sandell Scott D
Makhzoumi Mohamad
Florence Anthony A Jr
Behbahani Ali
Baskett Forest
NEA Partners 16 LP
New Enterprise Associates 16 LP
NEA 16 GP LLC
venBio Global Strategic Fund LP
venBio Global Strategic GP Ltd
Goodman Corey S
venBio Global Strategic GP LP
Adelman Robert J
Burow Kristina
Chen Hubert C
Lee Catherine Chai-zon
Millican Trisha
Polaris Entrepreneurs' Fund VII LP
Polaris Management Co VII LLC
Polaris Partners VII LP
Arch Venture Partners VIII LP
Bybee Clinton
Arch Venture Partners VIII LLC
Nelsen Robert
Arch Venture Fund VIII Overage LP
Arch Venture Fund VIII LP
Crandell Keith
Makower Joshua
Alexandria Venture Investments LLC
Gallagher Carol Giltner
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Metacrine Inc MTCR
Stock Option (right to buy) · derivative
2023-03-23 Disposed to issuer 842,211 $0.00
Metacrine Inc MTCR
Common Stock
2023-03-23 Grant 842,211 $0.47 395,839
Metacrine Inc MTCR
Common Stock
2023-01-26 Sell 107,054 $0.41 43,892
Metacrine Inc MTCR
Common Stock
2023-01-26 Sell 380,605 $0.41 156,048
Metacrine Inc MTCR
Common Stock
2022-12-21 Buy 120,099 $0.40 48,040
Metacrine Inc MTCR
Common Stock
2022-12-20 Buy 50,122 $0.38 19,046
Metacrine Inc MTCR
Common Stock
2022-12-19 Buy 101,384 $0.40 40,554
Metacrine Inc MTCR
Common Stock
2022-11-09 Buy 39,816 $0.39 15,528
Metacrine Inc MTCR
Common Stock
2022-11-08 Buy 500 $0.40 200
Metacrine Inc MTCR
Common Stock
2022-11-07 Buy 123,954 $0.42 52,061
Metacrine Inc MTCR
Common Stock
2022-10-28 Buy 45,022 $0.40 18,009
Metacrine Inc MTCR
Common Stock
2022-10-27 Buy 767,507 $0.39 299,328
Metacrine Inc MTCR
Common Stock
2022-10-26 Buy 588,533 $0.35 205,987
Metacrine Inc MTCR
Common Stock
2022-10-25 Buy 499,279 $0.35 174,748
Metacrine Inc MTCR
Common Stock
2022-10-24 Buy 174,354 $0.34 59,280
Metacrine Inc MTCR
Stock Option (right to buy) · derivative
2022-05-18 Grant 16,500 $0.00
Metacrine Inc MTCR
Stock Option (right to buy) · derivative
2022-05-18 Grant 16,500 $0.00
Metacrine Inc MTCR
Stock Option (right to buy) · derivative
2022-05-18 Grant 16,500 $0.00
Metacrine Inc MTCR
Stock Option (right to buy) · derivative
2022-05-18 Grant 16,500 $0.00
Metacrine Inc MTCR
Stock Option (right to buy) · derivative
2022-05-18 Grant 16,500 $0.00
showing 20 of 193 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com